Beau Ventures, LLc Portfolio

auto-discovered active 13F filer (filed within 180d).

SEC 13F CIK: 0002160035

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedTechnology TiltBuy & Hold how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025

Q3 2026 · 23 positions · Total reported value $1.06B · Top-10 concentration 95.8% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 4.3% · 1 new · 0 cut · 0 exited

Active Share (vs S&P 500): 92.3% · vs QQQ: 93.6% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, Beau Ventures, LLc disclosed 23 equity positions with a combined reported value of $1.06B. The filing implies a focused portfolio: its ten largest positions account for 95.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Technology Tilt / Buy & Hold.

The largest disclosed positions as of Q3 2026 were GOOG ($477.08M), MRNA ($192.58M), META ($145.07M). By sector, the heaviest allocations are Technology 64.4%, Health Care 26.1%. Versus the prior quarter, allocation shifted toward Health Care (+11.6pp) and away from Consumer Staples (-1.0pp), Consumer Discretionary (-1.4pp).

Versus the prior quarter, Beau Ventures, LLc opened 1 new positions, trimmed 0 and fully exited 0, a turnover rate of 4.3% of positions. The portfolio's overlap with the prior quarter was 96% of names.

The largest new positions opened in Q3 2026 were VYM ($245.99K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • VYM VANGUARD HIGH · $245.99K

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Beau Ventures, LLc buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Beau Ventures, LLc is an SEC-registered 13F filer. As of Q3 2026 it reported 23 US equity positions with a combined value of $1.06B. HoldingsHub carries 4 quarters of its filings (Q4 2025–Q3 2026).

Portfolio Structure

  • 23 positions · $1.06B reported value (Q3 2026)
  • Top 10 holdings = 95.8% of reported value
  • Largest position: GOOG (ALPHABET INC) at 45.0%
  • Average position size: $46.09M

Sector Tilt

  • Information Technology 64.4%
  • Health Care 26.1%
  • Consumer Discretionary 6.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 new
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintains a conservative stance, with a focus on stability and growth sectors. The holdings are evenly distributed across technology and health care, indicating a preference for companies with strong fundamentals and potential for long-term growth. 2. Key Moves: - New Position: The fund added a new position, likely a small-cap or emerging growth stock, given the total value of the portfolio and the addition of one new position. - No Reductions: There were no reductions in existing positions, suggesting a defensive strategy to maintain the current portfolio composition. 3. Portfolio Structure: - Passive vs. Active: The fund appears to be passive in nature, as there were no significant changes in holdings and the weightings remained stable. - Sector Bias: The portfolio is heavily biased towards technology and health care, reflecting a preference for sectors with strong growth prospects. - Risk Appetite: The risk appetite is moderate, as the fund maintains a diversified portfolio with no significant changes in risk profile. 4. Per-Holding One-Liner: - GOOG: Alphabet, a technology giant with a diverse portfolio of products and services, including Google Search, YouTube, and Google Cloud. - MRNA: Moderna, a biotechnology company specializing in mRNA-based therapies, known for its COVID-19 vaccine. - META: Meta Platforms, the parent company of Facebook, Instagram, and WhatsApp, focusing on social media and virtual reality. - ILMN: Illumina, a biotechnology company that develops and manufactures DNA sequencing and array-based technologies. - IBM: International Business Machines, a technology company that offers IT services, consulting, and hardware. - CVS: CVS Health, a healthcare company that operates pharmacies, provides healthcare services, and offers insurance plans. - ADBE: Adobe, a software company known for its creative suite of products, including Photoshop and Illustrator. - BIIB: Biogen, a biotechnology company focused on developing therapies for neurological and neurodegenerative diseases. - EBAY: eBay, an e-commerce platform that allows users to buy and sell goods and services online. - TGT: Target, a retail company that operates department stores, supermarkets, and a discount store chain. 5. One-Sentence Style Summary: Beau Ventures, LLC maintains a stable, passive investment strategy with a focus on technology and health care sectors, demonstrating a preference for established companies with strong growth potential.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 64.4%
Health Care 26.1%
Financials 0.9%
Other 0.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.40M $477.08M 45.01%
45.01%
Hold
2 1.00M $192.58M 18.17%
18.17%
Hold
3 200.05K $145.07M 13.69%
13.69%
Hold
4 200.08K $54.76M 5.17%
5.17%
Hold
5 158.53K $34.87M 3.29%
3.29%
Hold
6 325.43K $27.89M 2.63%
2.63%
Hold
7 100.08K $24.01M 2.27%
2.27%
Hold
8 100.00K $22.59M 2.13%
2.13%
Hold
9 200.00K $21.21M 2.00%
2.00%
Hold
10 100.00K $15.67M 1.48%
1.48%
Hold
11 380.89K $11.09M 1.05%
1.05%
Hold
12 28.23K $9.34M 0.88%
0.88%
Hold
13 100.52K $6.27M 0.59%
0.59%
Hold
14 573.55K $5.48M 0.52%
0.52%
Hold
15 50.00K $3.43M 0.32%
0.32%
Hold
16 436.47K $2.75M 0.26%
0.26%
Hold
17 10.00K $2.00M 0.19%
0.19%
Hold
18 10.04K $1.58M 0.15%
0.15%
Hold
19 100.00K $1.13M 0.11%
0.11%
Hold
20 10.00K $603.50K 0.06%
0.06%
Hold
21 50.00K $323.50K 0.03%
0.03%
Hold
22 1.58K $245.99K 0.02%
0.02%
New
23 90.00K $80.66K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 90% R 90% F1 90% (modelled on 2026-Q2; 9/10 hit)

Historical Backtest (2 quarters)

Avg precision 90% · recall 90% · F1 90% · avg rank error 1.1 · Top-10 turnover 7%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2026-Q2 90% 90% 90% GOOG · META · MRNA · IBM · ADBE · CVS · BIIB · EBAY · AMSC · TGT GOOG · META · MRNA · IBM · ILMN · CVS · EBAY · BIIB · ADBE · AMSC
2026-Q3 ★ 90% 90% 90% GOOG · META · MRNA · IBM · ILMN · CVS · EBAY · BIIB · ADBE · AMSC GOOG · MRNA · META · ILMN · IBM · CVS · ADBE · BIIB · EBAY · TGT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Beau Ventures, LLc buy in 2026-Q3?

In its 2026-Q3 13F filing, Beau Ventures, LLc reported 23 equity positions worth $1.06B in aggregate; its largest disclosed positions were GOOG ($477.08M), MRNA ($192.58M), META ($145.07M).

How large is Beau Ventures, LLc's portfolio?

Beau Ventures, LLc reported $1.06B of long equity holdings across 23 positions as of 2026-Q3. Top-10 holdings account for 95.8% of reported value.

What is Beau Ventures, LLc's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Technology Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/beau-ventures/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →